Outset Medical Inc (OM) FinancialsOMOutset Medical Inc

Outset Medical, Inc. (OM) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Consumables, accounting for 39.3% of total sales, equivalent to $12.42M. Other significant revenue streams include Services and other revenue and Consoles. Understanding this composition is critical for investors evaluating how OM navigates market cycles within the Advanced Medical Equipment & Technology industry.

Evaluating the bottom line, Outset Medical, Inc. maintains a gross margin of 41.99%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -49.55%, while the net margin is -56.85%. These profitability ratios, combined with a Return on Equity (ROE) of -60.09%, provide a clear picture of how effectively OM converts its operational activities into shareholder value.

In the context of the broader market, OM competes directly with industry leaders such as CRDF and NRXS. With a market capitalization of $84.78M, it holds a leading position in the sector. When comparing efficiency, OM's gross margin of 41.99% stands against CRDF's 100.00% and NRXS's 85.87%. Such benchmarking helps identify whether Outset Medical, Inc. is trading at a premium or discount relative to its financial performance.

Outset Medical has shown declining revenue with a total revenue of $31,635,000 in Q2 2026, down from $31,419,000 in Q2 2025. The gross margin is relatively strong at 41.99%, but the company has consistently reported negative net income, with a net income of -$17,984,000 in Q2 2026.